Does PERTUZUMAB Cause Ejection fraction decreased? 644 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 644 reports of Ejection fraction decreased have been filed in association with PERTUZUMAB (PERJETA). This represents 2.9% of all adverse event reports for PERTUZUMAB.
644
Reports of Ejection fraction decreased with PERTUZUMAB
2.9%
of all PERTUZUMAB reports
64
Deaths
225
Hospitalizations
How Dangerous Is Ejection fraction decreased From PERTUZUMAB?
Of the 644 reports, 64 (9.9%) resulted in death, 225 (34.9%) required hospitalization, and 30 (4.7%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
Yes, Ejection fraction decreased is listed as a known adverse reaction in the official FDA drug label for PERTUZUMAB.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
FUROSEMIDE (283)
Which PERTUZUMAB Alternatives Have Lower Ejection fraction decreased Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN